KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 171 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 2.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $51,565 | -57.4% | 28,807 | -7.3% | 0.00% | -100.0% |
Q1 2023 | $120,940 | +75.5% | 31,090 | +53.4% | 0.00% | 0.0% |
Q4 2022 | $68,908 | -35.0% | 20,267 | +4.3% | 0.00% | 0.0% |
Q3 2022 | $106,000 | +27.7% | 19,423 | +5.1% | 0.00% | 0.0% |
Q2 2022 | $83,000 | -38.5% | 18,474 | +0.5% | 0.00% | 0.0% |
Q1 2022 | $135,000 | +14.4% | 18,379 | +0.5% | 0.00% | 0.0% |
Q4 2021 | $118,000 | +24.2% | 18,288 | +11.8% | 0.00% | 0.0% |
Q3 2021 | $95,000 | -43.1% | 16,364 | +0.8% | 0.00% | 0.0% |
Q2 2021 | $167,000 | +5.7% | 16,230 | +8.2% | 0.00% | 0.0% |
Q1 2021 | $158,000 | -31.6% | 14,998 | +0.5% | 0.00% | -50.0% |
Q4 2020 | $231,000 | +2.7% | 14,916 | -3.4% | 0.00% | 0.0% |
Q3 2020 | $225,000 | +14.8% | 15,444 | +49.1% | 0.00% | -33.3% |
Q2 2020 | $196,000 | -13.7% | 10,356 | -12.2% | 0.00% | -25.0% |
Q1 2020 | $227,000 | – | 11,793 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 4,767,078 | $80,993,000 | 5.22% |
Palo Alto Investors LP | 4,663,324 | $79,230,000 | 3.17% |
DOHENY ASSET MANAGEMENT /CA | 282,945 | $4,807,000 | 2.61% |
Private Capital Advisors, Inc. | 416,900 | $7,083,000 | 2.22% |
Sandia Holdings, LLC | 119,739 | $2,034,000 | 0.91% |
Virtus ETF Advisers LLC | 44,986 | $764,000 | 0.68% |
Birchview Capital, LP | 50,000 | $850,000 | 0.58% |
Schonfeld Strategic Advisors LLC | 415,600 | $7,061,000 | 0.38% |
EMERALD ADVISERS, LLC | 561,317 | $9,537,000 | 0.36% |
Kazazian Asset Management, LLC | 20,672 | $351,000 | 0.32% |